Filed: 2/14/2025ACC: 0001839435-25-000002
📋 What this filing means
OCTAGON CAPITAL ADVISORS LP filed this quarterly 13F‑HR report disclosing 31 equity positions with a total reported market value of $607.70M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
31
Positions
$607.70M
Total AUM (reported)
99.89M
Total Shares
Allocation by class
COM$414.27M68.2%
SPONSORED ADS$62.46M10.3%
COM NEW$44.77M7.4%
COM PAR$40.18M6.6%
COM CL A$24.48M4.0%
COM SHS$18.08M3.0%
CL A ORD SHS$2.63M0.4%
Portfolio Concentration
Top 3$196.82M32.4%
4–10$190.77M31.4%
11–25$200.35M33.0%
Rest$19.77M3.3%
Top 3 weight
32.4%
Top 10 weight
63.8%
Voting Authority Distribution
Total shares with voting rights: 99.89M
Sole
Full voting authority
99.89M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole31
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings31
Rows:
APELLIS PHARMACEUTICALS INC
SOLEShares3.01M
TypeSH
Market value$95.95M
15.79%
Sole
3.01M
Shared
0.00
None
0.00
ARRIVENT BIOPHARMA INC
SOLEShares2.06M
TypeSH
Market value$54.86M
9.03%
Sole
2.06M
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares2.11M
TypeSH
Market value$46.00M
7.57%
Sole
2.11M
Shared
0.00
None
0.00
INSMED INC
SOLEShares582K
TypeSH
Market value$40.18M
6.61%
Sole
582K
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares2.15M
TypeSH
Market value$35.93M
5.91%
Sole
2.15M
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares571.26K
TypeSH
Market value$26.53M
4.37%
Sole
571.26K
Shared
0.00
None
0.00
NUVATION BIO INC
SOLEShares9.20M
TypeSH
Market value$24.48M
4.03%
Sole
9.20M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares2.76M
TypeSH
Market value$21.55M
3.55%
Sole
2.76M
Shared
0.00
None
0.00
SCHOLAR ROCK HLDG CORP
SOLEShares488K
TypeSH
Market value$21.09M
3.47%
Sole
488K
Shared
0.00
None
0.00
MIND MEDICINE MINDMED INC
SOLEShares3.02M
TypeSH
Market value$21.01M
3.46%
Sole
3.02M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares2.42M
TypeSH
Market value$20.71M
3.41%
Sole
2.42M
Shared
0.00
None
0.00
TAYSHA GENE THERAPIES INC
SOLEShares10.45M
TypeSH
Market value$18.08M
2.97%
Sole
10.45M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares870K
TypeSH
Market value$16.68M
2.74%
Sole
870K
Shared
0.00
None
0.00
GOSSAMER BIO INC
SOLEShares18.35M
TypeSH
Market value$16.60M
2.73%
Sole
18.35M
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares668K
TypeSH
Market value$15.74M
2.59%
Sole
668K
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares778K
TypeSH
Market value$14.91M
2.45%
Sole
778K
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HLDGS
SOLEShares1.11M
TypeSH
Market value$13.16M
2.17%
Sole
1.11M
Shared
0.00
None
0.00
MERUS N V
SOLEShares308K
TypeSH
Market value$12.95M
2.13%
Sole
308K
Shared
0.00
None
0.00
ERASCA INC
SOLEShares5.14M
TypeSH
Market value$12.89M
2.12%
Sole
5.14M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares441.60K
TypeSH
Market value$12.12M
1.99%
Sole
441.60K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares904K
TypeSH
Market value$11.95M
1.97%
Sole
904K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares1.37M
TypeSH
Market value$11.60M
1.91%
Sole
1.37M
Shared
0.00
None
0.00
UNICYCIVE THERAPEUTICS INC
SOLEShares10M
TypeSH
Market value$7.94M
1.31%
Sole
10M
Shared
0.00
None
0.00
REGULUS THERAPEUTICS INC
SOLEShares4.85M
TypeSH
Market value$7.66M
1.26%
Sole
4.85M
Shared
0.00
None
0.00
PERSPECTIVE THERAPEUTICS INC
SOLEShares2.30M
TypeSH
Market value$7.35M
1.21%
Sole
2.30M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
APELLIS PHARMACEUTICALS INCSOLE | COM | 3.01M | SH | $95.95M 15.79% | 3.01M | 0.00 | 0.00 |
ARRIVENT BIOPHARMA INCSOLE | COM | 2.06M | SH | $54.86M 9.03% | 2.06M | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 2.11M | SH | $46.00M 7.57% | 2.11M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR | 582K | SH | $40.18M 6.61% | 582K | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 2.15M | SH | $35.93M 5.91% | 2.15M | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 571.26K | SH | $26.53M 4.37% | 571.26K | 0.00 | 0.00 |
NUVATION BIO INCSOLE | COM CL A | 9.20M | SH | $24.48M 4.03% | 9.20M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 2.76M | SH | $21.55M 3.55% | 2.76M | 0.00 | 0.00 |
SCHOLAR ROCK HLDG CORPSOLE | COM | 488K | SH | $21.09M 3.47% | 488K | 0.00 | 0.00 |
MIND MEDICINE MINDMED INCSOLE | COM NEW | 3.02M | SH | $21.01M 3.46% | 3.02M | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 2.42M | SH | $20.71M 3.41% | 2.42M | 0.00 | 0.00 |
TAYSHA GENE THERAPIES INCSOLE | COM SHS | 10.45M | SH | $18.08M 2.97% | 10.45M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 870K | SH | $16.68M 2.74% | 870K | 0.00 | 0.00 |
GOSSAMER BIO INCSOLE | COM | 18.35M | SH | $16.60M 2.73% | 18.35M | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 668K | SH | $15.74M 2.59% | 668K | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 778K | SH | $14.91M 2.45% | 778K | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HLDGSSOLE | COM NEW | 1.11M | SH | $13.16M 2.17% | 1.11M | 0.00 | 0.00 |
MERUS N VSOLE | COM | 308K | SH | $12.95M 2.13% | 308K | 0.00 | 0.00 |
ERASCA INCSOLE | COM | 5.14M | SH | $12.89M 2.12% | 5.14M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 441.60K | SH | $12.12M 1.99% | 441.60K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 904K | SH | $11.95M 1.97% | 904K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 1.37M | SH | $11.60M 1.91% | 1.37M | 0.00 | 0.00 |
UNICYCIVE THERAPEUTICS INCSOLE | COM | 10M | SH | $7.94M 1.31% | 10M | 0.00 | 0.00 |
REGULUS THERAPEUTICS INCSOLE | COM | 4.85M | SH | $7.66M 1.26% | 4.85M | 0.00 | 0.00 |
PERSPECTIVE THERAPEUTICS INCSOLE | COM NEW | 2.30M | SH | $7.35M 1.21% | 2.30M | 0.00 | 0.00 |
Page 1 of 2